NCT05980117View on ClinicalTrials.gov

Remimazolam for Cataract Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Cataract SurgeryCognitive Impairment
Interventions
DRUG

Remimazolam

Remimazolam (1.0mg IV) titrated to modified observer's assessment of sedation score of 3 -4 during cataract surgery.

DRUG

Midazolam

Midazolam (0.5-2mg IV) titrated to modified observer's assessment of sedation score of 3 - 4 during cataract surgery.

Trial Locations (1)

90095

RECRUITING

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER